Prenatal cocaine/polydrug exposure and infant performance on an executive functioning task

Julia S Noland1, Lynn T Singer, Sudhir K Mehta

  • 1Department of Pediatrics and General Medical Sciences, Case Western Reserve University, USA. jsn4@po.cwru.edu

Insights

Infants exposed to higher levels of prenatal cocaine showed deficits in executive function, specifically in the A-not-B task. These findings suggest potential long-term cognitive impacts of prenatal cocaine exposure.

Area of Science:

  • Neuroscience
  • Developmental Psychology
  • Pediatrics

Background:

  • Prenatal exposure to substances like cocaine can impact infant development.
  • Executive functioning skills begin to emerge in infancy.
  • Polydrug exposure (marijuana, alcohol, tobacco) often co-occurs with cocaine use.

Purpose of the Study:

  • To assess executive functioning in cocaine-exposed (CE) infants compared to controls.
  • To investigate the impact of heavier prenatal cocaine exposure on infant cognitive and motor development.
  • To explore potential mediators and confounders in the relationship between prenatal cocaine exposure and infant development.

Main Methods:

  • Assessed executive functioning using an A-not-B task in infants aged 9.5-12.5 months.
  • Compared heavier-CE infants to lighter-CE and non-CE infants.
  • Analyzed covariates including socioeconomic status, gestational age, birth weight, and other substance exposures.

Main Results:

  • No overall difference in executive functioning between all CE and non-CE infants.
  • Heavier-CE infants showed significant differences in A-not-B performance and global development tests.
  • Gestational length mediated motor development; cigarette use confounded mental development.
  • A-not-B performance remained significant after controlling for some variables but not global mental development.

Conclusions:

  • Heavier prenatal cocaine exposure is associated with specific executive functioning deficits (A-not-B task) in infancy.
  • While some developmental impacts are mediated or confounded by other factors, A-not-B performance shows a robust association.
  • Findings highlight the importance of considering dose-dependent effects and co-exposures in prenatal substance research.